Sen. Michael E. Hastings
Filed: 3/15/2019
 
 

 

 

 
10100SB1715sam001LRB101 08622 RAB 57742 a



1
AMENDMENT TO SENATE BILL 1715 




2    AMENDMENT NO. ______. Amend Senate Bill 1715 as follows:
 

3on page 3, by adding the following after line 20:


4            "(B-5) following the initial administration of 
5        long-acting or extended release form opioid 
6        antagonists by a physician licensed to practice 
7        medicine in all its branches, administration of 
8        injections of long-acting or extended-release form 
9        opioid antagonists for the treatment of substance use 
10        disorder, pursuant to a valid prescription by a 
11        physician licensed to practice medicine in all its 
12        branches, upon completion of appropriate training, 
13        including how to address contraindications and adverse 
14        reactions, including, but not limited to, respiratory 
15        depression and the performance of cardiopulmonary 
16        resuscitation, set forth by rule, with notification to 
17        the patient's physician and appropriate record 
 
 
10100SB1715sam001- 2 -LRB101 08622 RAB 57742 a

1        retention, or pursuant to hospital pharmacy and 
2        therapeutics committee policies and procedures;"; and

 
3on page 4, line 9 by adding the following after "training":

4"conducted by an Accreditation Council of Pharmaceutical 
5Education accredited provider".